10-Q
1falseQ3--12-31100018666920001866692us-gaap:CommonClassBMember2021-09-300001866692ampl:ClassAAndClassBCommonStockMember2020-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2020-01-012020-03-310001866692us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001866692ampl:ClassAAndClassBCommonStockMember2020-01-012020-03-310001866692us-gaap:RetainedEarningsMember2021-01-012021-03-310001866692srt:MaximumMember2020-09-300001866692us-gaap:SalesRevenueNetMemberampl:OneCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-07-012021-09-300001866692ampl:RSUsMember2020-07-012020-09-300001866692us-gaap:CommonClassBMember2021-11-030001866692us-gaap:RestrictedStockMember2020-01-012020-09-300001866692srt:MinimumMember2020-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2021-04-012021-06-300001866692ampl:WarrantsMember2021-01-012021-09-300001866692us-gaap:RetainedEarningsMember2020-12-310001866692ampl:SeriesFRedeemableConvertiblePreferredStockMember2021-09-300001866692ampl:TwoThousandFourteenStockOptionPlanMember2021-01-012021-09-3000018666922021-01-012021-03-310001866692us-gaap:SellingAndMarketingExpenseMember2020-07-012020-09-300001866692ampl:DevelopedTechnologyMember2021-01-012021-09-3000018666922020-01-012020-12-310001866692srt:MinimumMember2021-01-012021-09-300001866692us-gaap:RetainedEarningsMember2019-12-310001866692ampl:TwoThousandsTwentyOneEmployeeStockPurchasePlanMember2021-01-012021-09-300001866692us-gaap:EmployeeStockOptionMember2021-07-012021-09-300001866692us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001866692ampl:RSUsMember2021-01-012021-09-300001866692us-gaap:RetainedEarningsMember2021-03-310001866692ampl:RSUsMemberampl:TwoThousandFourteenStockOptionPlanMember2021-09-300001866692ampl:ClassAAndClassBCommonStockMember2020-03-310001866692us-gaap:RedeemableConvertiblePreferredStockMember2020-06-300001866692us-gaap:EmployeeStockOptionMemberampl:OptionAndGrantPlanMember2020-12-310001866692ampl:ClassAAndClassBCommonStockMember2020-04-012020-06-300001866692ampl:EquityPlanStockOptionsOutstandingMember2020-12-310001866692us-gaap:SeriesFPreferredStockMember2021-09-300001866692us-gaap:CostOfSalesMember2021-01-012021-09-3000018666922020-12-310001866692us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001866692ampl:ClassAAndClassBCommonStockMember2021-06-300001866692ampl:ClassAAndClassBCommonStockMember2021-03-310001866692us-gaap:RedeemableConvertiblePreferredStockMember2020-04-012020-06-300001866692us-gaap:EmployeeStockOptionMember2020-01-012020-09-300001866692us-gaap:WarrantMember2020-12-3100018666922020-04-012020-06-3000018666922020-09-300001866692ampl:PrivatelyHeldCompanyMember2021-09-300001866692ampl:TwoThousandsTwentyOneIncentiveAwardPlanMember2021-09-300001866692ampl:EquityPlanStockOptionsEarlyExercisedMember2021-01-012021-09-300001866692ampl:ClassAAndClassBCommonStockMember2021-01-012021-03-310001866692ampl:TwoThousandsTwentyOneIncentiveAwardPlanMemberus-gaap:CommonClassAMember2021-09-300001866692ampl:ClassAAndClassBCommonStockMember2020-06-300001866692us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001866692us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300001866692us-gaap:RetainedEarningsMember2020-03-3100018666922021-09-300001866692us-gaap:SeriesDPreferredStockMember2021-09-300001866692us-gaap:RetainedEarningsMember2020-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2021-01-012021-09-300001866692us-gaap:CostOfSalesMember2020-01-012020-09-300001866692ampl:NoCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-09-300001866692us-gaap:SalesRevenueNetMemberampl:OneCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001866692ampl:DevelopedTechnologyMember2020-09-300001866692ampl:ClassAAndClassBCommonStockMember2020-07-012020-09-300001866692us-gaap:SellingAndMarketingExpenseMember2021-01-012021-09-300001866692ampl:ClassAAndClassBCommonStockMember2020-12-310001866692us-gaap:RetainedEarningsMember2021-06-3000018666922021-01-012021-09-300001866692us-gaap:ResearchAndDevelopmentExpenseMember2020-07-012020-09-300001866692us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberampl:TwoCustomerMember2020-01-012020-12-310001866692ampl:NonPlanStockOptionsMember2020-01-012020-09-300001866692srt:MinimumMember2020-01-012020-09-300001866692us-gaap:SeriesBPreferredStockMember2021-09-300001866692us-gaap:RestrictedStockMember2021-01-012021-09-300001866692us-gaap:RetainedEarningsMember2021-09-300001866692us-gaap:GeneralAndAdministrativeExpenseMember2021-07-012021-09-300001866692ampl:TwoThousandFourteenStockOptionPlanMember2021-09-300001866692us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001866692us-gaap:SeriesEPreferredStockMember2021-09-300001866692us-gaap:CustomerRelatedIntangibleAssetsMember2021-09-300001866692country:US2020-01-012020-09-300001866692ampl:TwoThousandsTwentyOneEmployeeStockPurchasePlanMemberus-gaap:CommonClassAMember2021-07-012021-09-300001866692ampl:InternationalMember2020-07-012020-09-300001866692ampl:SeriesARedeemableConvertiblePreferredStockMember2021-09-300001866692us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-09-300001866692us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-09-300001866692us-gaap:RestrictedStockUnitsRSUMember2020-12-310001866692srt:MinimumMember2021-09-300001866692ampl:EquityPlanStockOptionsEarlyExercisedMember2020-01-012020-09-300001866692us-gaap:CommonClassAMember2021-09-300001866692us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012021-09-300001866692us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001866692ampl:TwoThousandsTwentyOneEmployeeStockPurchasePlanMemberus-gaap:CommonClassAMember2021-09-300001866692ampl:RSUsMember2020-01-012020-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2021-06-300001866692srt:MaximumMember2021-09-300001866692us-gaap:AdditionalPaidInCapitalMember2019-12-310001866692us-gaap:CustomerRelatedIntangibleAssetsMember2020-09-300001866692ampl:RSUsMemberampl:TwoThousandFourteenStockOptionPlanMember2021-01-012021-09-300001866692us-gaap:CustomerRelatedIntangibleAssetsMember2021-01-012021-09-300001866692us-gaap:RetainedEarningsMember2021-07-012021-09-300001866692ampl:DevelopedTechnologyMember2021-09-300001866692us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001866692us-gaap:AdditionalPaidInCapitalMember2021-06-300001866692us-gaap:SeriesAPreferredStockMember2021-09-300001866692country:US2020-07-012020-09-300001866692srt:MaximumMember2020-01-012020-09-3000018666922021-07-012021-09-300001866692us-gaap:CommonClassAMember2021-01-012021-09-300001866692ampl:DirectListingMember2021-01-012021-09-300001866692ampl:TwoThousandsTwentyOneEmployeeStockPurchasePlanMember2021-09-3000018666922020-07-012020-09-300001866692ampl:WarrantsMember2020-01-012020-09-300001866692ampl:NoCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-09-300001866692ampl:NonPlanStockOptionsMember2021-01-012021-09-300001866692us-gaap:AdditionalPaidInCapitalMember2021-03-310001866692us-gaap:CommonClassAMember2021-11-030001866692us-gaap:GeneralAndAdministrativeExpenseMember2020-07-012020-09-300001866692us-gaap:RetainedEarningsMember2020-01-012020-03-310001866692us-gaap:SellingAndMarketingExpenseMember2020-01-012020-09-300001866692ampl:ClassAAndClassBCommonStockMember2019-12-3100018666922020-03-310001866692ampl:TwoThousandsTwentyOneIncentiveAwardPlanMember2021-01-012021-09-300001866692ampl:SecondaryTransactionsMember2021-01-012021-09-300001866692ampl:SecondaryTransactionsMember2020-01-012020-09-300001866692ampl:NoCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2021-07-012021-09-300001866692us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-09-300001866692us-gaap:AdditionalPaidInCapitalMember2020-12-310001866692ampl:ClassAAndClassBCommonStockMember2021-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2021-09-300001866692us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-09-3000018666922021-04-012021-06-300001866692ampl:NonPlanStockOptionsMember2020-12-310001866692ampl:EquityPlanStockOptionsOutstandingMember2020-01-012020-09-300001866692us-gaap:AdditionalPaidInCapitalMember2020-06-3000018666922021-03-310001866692country:US2021-07-012021-09-300001866692ampl:RSUsMember2021-07-012021-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2021-03-310001866692ampl:EquityPlanStockOptionsOutstandingMember2021-01-012021-09-300001866692ampl:NoCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-07-012020-09-300001866692us-gaap:RetainedEarningsMember2021-04-012021-06-3000018666922021-06-300001866692us-gaap:RetainedEarningsMember2020-04-012020-06-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2020-01-012020-09-300001866692ampl:PrivatelyHeldCompanyMember2021-01-012021-09-300001866692ampl:InternationalMember2021-01-012021-09-300001866692ampl:InternationalMember2020-01-012020-09-300001866692ampl:SecondaryTransactionsMember2021-07-012021-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2019-12-310001866692us-gaap:EmployeeStockOptionMember2021-01-012021-09-300001866692us-gaap:EmployeeStockOptionMemberampl:TwoExecutivesMember2020-12-012020-12-310001866692us-gaap:AdditionalPaidInCapitalMember2020-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2021-09-300001866692us-gaap:CommonClassBMember2021-01-012021-09-300001866692us-gaap:AdditionalPaidInCapitalMember2021-09-300001866692ampl:RestrictedStockUnitsOutstandingMember2021-01-012021-09-300001866692us-gaap:RestrictedStockUnitsRSUMember2021-09-300001866692ampl:SecondaryTransactionsMember2020-07-012020-09-300001866692us-gaap:CostOfSalesMember2021-07-012021-09-300001866692us-gaap:RetainedEarningsMember2020-06-300001866692us-gaap:SellingAndMarketingExpenseMember2021-07-012021-09-300001866692us-gaap:CommonClassAMember2020-12-310001866692srt:MaximumMember2021-01-012021-09-300001866692us-gaap:CostOfSalesMember2020-07-012020-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2020-12-310001866692us-gaap:RetainedEarningsMember2020-07-012020-09-300001866692ampl:ClassAAndClassBCommonStockMember2021-04-012021-06-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2020-09-3000018666922020-01-012020-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2020-03-310001866692us-gaap:AdditionalPaidInCapitalMember2020-03-310001866692ampl:RestrictedStockUnitsOutstandingMember2020-01-012020-09-300001866692ampl:DirectListingMember2021-07-012021-09-300001866692us-gaap:RedeemableConvertiblePreferredStockMember2021-07-012021-09-300001866692us-gaap:CommonClassBMember2020-12-3100018666922020-06-300001866692ampl:DirectListingMember2021-09-3000018666922020-01-012020-03-3100018666922019-12-310001866692ampl:EquityPlanStockOptionsOutstandingMember2021-09-300001866692country:US2021-01-012021-09-300001866692us-gaap:SeriesCPreferredStockMember2021-09-300001866692ampl:ClassAAndClassBCommonStockMember2021-07-012021-09-300001866692ampl:InternationalMember2021-07-012021-09-30iso4217:USDxbrli:sharesxbrli:purexbrli:sharesampl:Segmentiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-40817

 

AMPLITUDE, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

45-3937349

( State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

201 Third Street, Suite 200

San Francisco, California

94103

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (650) 988-5131

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock, $0.00001 par value per share

 

AMPL

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of November 3, 2021, there were 53,879,646 shares of the registrant's Class A common stock and 55,015,748 shares of the registrant's Class B common stock, each with a $0.00001 par value per share, outstanding.

 

 

 

 


 

Table of Contents

 

 

 

Page

PART I.

FINANCIAL INFORMATION

6

Item 1.

Financial Statements (Unaudited)

6

 

Condensed Consolidated Balance Sheets

6

 

Condensed Consolidated Statements of Operations

7

 

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)

8

 

Condensed Consolidated Statements of Cash Flows

10

 

Notes to Condensed Consolidated Financial Statements

11

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

22

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

37

Item 4.

Controls and Procedures

38

PART II.

OTHER INFORMATION

39

Item 1.

Legal Proceedings

39

Item 1A.

Risk Factors

39

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

68

Item 3.

Defaults Upon Senior Securities

68

Item 4.

Mine Safety Disclosures

68

Item 5.

Other Information

68

Item 6.

Exhibits

69

Signatures

71

 

 

2


 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q may be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “forecasts,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to statements about:

the effects of the coronavirus ("COVID-19") pandemic, including as a result of the recent Delta variant and any new strains or variants of the virus, on our business and the global economy generally;
our expectations regarding our revenue, expenses, and other operating results;
our ability to acquire new customers;
our ability to increase usage of our Digital Optimization System and upsell and cross sell additional products;
our ability to achieve or sustain our profitability;
future investments in our business, our anticipated capital expenditures, and our estimates regarding our capital requirements;
the costs and success of our sales and marketing efforts, including our ability to grow and maintain our channel partners, and our ability to promote our brand;
our reliance on key personnel and our ability to identify, recruit and retain skilled personnel;
our ability to effectively manage our growth, including any international expansion;
our ability to protect our intellectual property rights and any costs associated therewith;
our ability to compete effectively with existing competitors and new market entrants; and
the increased expenses associated with being a public company.

 

 

3


 

We caution you that the foregoing list does not contain all of the forward-looking statements made in this Quarterly Report on Form 10-Q.

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations, estimates, forecasts, and projections about future events and trends that we believe may affect our business, results of operations, financial condition, and prospects. Although we believe that we have a reasonable basis for each forward-looking statement contained in this Quarterly Report on Form 10-Q, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur at all. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors discussed in Part II, Item 1A, “Risk Factors” in this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made available. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and you are cautioned not to unduly rely upon these statements.

You should read this Quarterly Report on Form 10-Q and the documents that we reference in this Quarterly Report on Form 10-Q and have filed as exhibits to this Quarterly Report on Form 10-Q, completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in this Quarterly Report on Form 10-Q by these cautionary statements.

 

4


 

SUMMARY OF RISK FACTORS

 

Our business is subject to numerous risks and uncertainties, including those described in Part II, Item 1A, “Risk Factors” in this Quarterly Report on Form 10-Q. The following is a summary of principal risks and uncertainties that could materially adversely affect our business, financial condition, and results of operations. This summary should be read in conjunction with the “Risk Factors” section and should not be relied upon as an exhaustive summary of the material risks and uncertainties facing our business.

We have a limited operating history and have been growing rapidly over the last several years, which makes it difficult to forecast our future results of operations and increases the risk of your investment.
We have a history of losses. As our costs increase, we may not be able to generate sufficient revenue to achieve and sustain profitability.
Our business depends on our current customers renewing their subscriptions and purchasing additional subscriptions from us, as well as attracting new customers. Any decline in our customer retention or expansion of our commercial relationships with existing customers or an inability to attract new customers would materially adversely affect our business, financial condition, and results of operations.
We expect fluctuations in our financial results, making it difficult to project future results. If we fail to meet the expectations of securities analysts or investors with respect to our results of operations, our stock price could decline.
We expect to continue to focus on sales to larger organizations and may become more dependent on those relationships, which may increase the variability of our sales cycles and our results of operations.
We recognize revenue over the term of our customer contracts. Consequently, downturns or upturns in new sales may not be immediately reflected in our results of operations and may be difficult to discern.
Unfavorable conditions in our industry or the global economy, or reductions in information technology spending, could limit our ability to grow our business and materially adversely affect our business, financial condition, and results of operations.
If the market for SaaS applications develops more slowly than we expect or declines, our business would be adversely affected.
Our intellectual property rights may not protect our business or provide us with a competitive advantage, which could have a material adverse effect on our business, financial condition, and results of operations.
We are subject to government regulation, including import, export, economic sanctions, and anti-corruption laws and regulations, that may expose us to liability and increase our costs.
Complying with evolving privacy and other data-related laws as well as contractual and other requirements may be expensive and force us to make adverse changes to our business, and the failure or perceived failure to comply with such laws, contracts, and other requirements could result in adverse reputational and brand damage and significant fines and liability or otherwise materially adversely affect our business and growth prospects.
Our stock price may be volatile, and could decline significantly and rapidly.
Our principal stockholders have the ability to influence the outcome of director elections and other matters requiring stockholder approval.
The dual class structure of our common stock has the effect of concentrating voting control with our existing stockholders, executive officers, directors, and their affiliates, which limits your ability to influence the outcome of important transactions and to influence corporate governance matters, such as electing directors, and to approve material mergers, acquisitions, or other business combination transactions that may not be aligned with your interests.
None of our stockholders are party to any contractual lock-up agreement or other contractual restrictions on transfer. Sales of substantial amounts of our Class A common stock in the public markets, or the perception that sales might occur, could cause the trading price of our Class A common stock to decline.

 

5


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

AMPLITUDE, INC.

Condensed Consolidated Balance Sheets

(In thousands, except per share amounts)

(unaudited)

 

 

 

As of
September 30,
2021

 

 

As of
December 31,
2020

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

317,763

 

 

$

117,783

 

Restricted cash, current

 

 

1,081

 

 

 

1,080

 

Accounts receivable, net of allowance for doubtful accounts of $63 and
   $
162 as of September 30, 2021 and December 31, 2020, respectively

 

 

22,834

 

 

 

17,396

 

Prepaid expenses and other current assets

 

 

18,826

 

 

 

6,857

 

Deferred commissions, current

 

 

7,427

 

 

 

5,563

 

Total current assets

 

 

367,931

 

 

 

148,679

 

Property and equipment, net

 

 

3,886

 

 

 

2,673

 

Intangible assets, net

 

 

4,054

 

 

 

1,955

 

Goodwill

 

 

4,073

 

 

 

1,000

 

Restricted cash, noncurrent

 

 

850

 

 

 

 

Deferred commissions, noncurrent

 

 

18,683

 

 

 

13,877

 

Other noncurrent assets

 

 

10,424

 

 

 

6,898

 

Total assets

 

$

409,901

 

 

$

175,082

 

LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND
   STOCKHOLDERS' EQUITY (DEFICIT)

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

3,218

 

 

$

4,417

 

Accrued expenses

 

 

24,836

 

 

 

8,110

 

Deferred revenue

 

 

71,457

 

 

 

40,797

 

Total current liabilities

 

 

99,511

 

 

 

53,324

 

Noncurrent liabilities

 

 

2,142

 

 

 

1,067

 

Total liabilities

 

 

101,653

 

 

 

54,391

 

Commitments and contingencies (Note 8)

 

 

 

 

 

 

Redeemable convertible preferred stock:

 

 

 

 

 

 

Redeemable convertible preferred stock, $0.00001 par value per share; zero and
   
61,740 shares authorized as of September 30, 2021 and December 31, 2020,
   respectively;
zero and 61,717 shares issued and outstanding as of September 30, 2021
   and December 31, 2020, respectively; aggregate liquidation preference of
zero and
   $
192,074 as of September 30, 2021 and December 31, 2020, respectively

 

 

 

 

 

187,811

 

Stockholders' equity (deficit):

 

 

 

 

 

 

Preferred stock, $0.00001 par value per share; 20,000 and zero shares authorized as
   of September 30, 2021 and December 31, 2020, respectively;
zero shares issued
   and outstanding as of September 30, 2021 and December 31, 2020, respectively

 

 

 

 

 

 

Class A common stock, $0.00001 par value per share; 600,000 and zero shares authorized
   as of September 30, 2021 and December 31, 2020, respectively;
51,669 and zero shares
   issued and outstanding as of September 30, 2021 and December 31, 2020, respectively

 

 

 

 

 

 

Class B common stock, $0.00001 par value per share; 600,000 and 118,600 shares
   authorized as of September 30, 2021 and December 31, 2020, respectively;
56,006 and
   
27,924 shares issued and outstanding as of September 30, 2021 and December 31, 2020,
   respectively

 

 

1

 

 

 

 

Additional paid-in capital

 

 

466,152

 

 

 

37,704

 

Accumulated deficit

 

 

(157,905

)

 

 

(104,824

)

Total stockholders’ equity (deficit)

 

 

308,248

 

 

 

(67,120

)

Total liabilities, redeemable convertible preferred stock and stockholders’
   equity (deficit)

 

$

409,901

 

 

$

175,082

 

 

See accompanying notes to condensed consolidated financial statements.

6


 

AMPLITUDE, INC.

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

(unaudited)

 

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Revenue

 

$

45,473

 

 

$

26,366

 

 

$

117,837

 

 

$

72,388

 

Cost of revenue

 

 

13,982

 

 

 

7,765

 

 

 

36,372

 

 

 

21,281

 

Gross profit

 

 

31,491

 

 

 

18,601

 

 

 

81,465

 

 

 

51,107

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

18,493

 

 

 

5,586

 

 

 

34,022

 

 

 

19,727

 

Sales and marketing

 

 

22,199

 

 

 

11,482

 

 

 

59,009

 

 

 

36,851

 

General and administrative

 

 

27,567

 

 

 

3,918

 

 

 

41,098

 

 

 

13,416

 

Total operating expenses

 

 

68,259

 

 

 

20,986

 

 

 

134,129

 

 

 

69,994

 

Other income (expense), net

 

 

123

 

 

 

18

 

 

 

143

 

 

 

245

 

Loss before provision for (benefit from) income taxes

 

 

(36,645

)

 

 

(2,367

)

 

 

(52,521

)

 

 

(18,642

)

Provision for (benefit from) income taxes

 

 

(86

)

 

 

207

 

 

 

560

 

 

 

555

 

Net loss

 

$

(36,559

)

 

$

(2,574

)

 

$

(53,081

)

 

$

(19,197

)

Net loss per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

(0.93

)

 

 

(0.10

)

 

 

(1.64

)

 

 

(0.78

)

Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

39,301

 

 

 

25,147

 

 

 

32,362

 

 

 

24,750

 

 

See accompanying notes to condensed consolidated financial statements.

 

 

7


 

AMPLITUDE, INC.

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)

(In thousands)

(unaudited)

 

 

 

Redeemable convertible
preferred stock

 

 

Class A and Class B common stock

 

 

 

Additional
paid-in

 

 

 

Accumulated

 

 

 

Total
stockholders’

 

 

 

Shares

 

 

 

Amount

 

 

Shares

 

 

 

Amount

 

 

 

capital

 

 

 

deficit

 

 

 

equity (deficit)

 

Balance at December 31, 2019

 

 

56,480

 

 

 $

 

137,991

 

 

 

24,646

 

 

 $

 

-

 

 

 $

 

17,378

 

 

 $

 

(80,257

)

 

 $

 

(62,879

)

Issuance of redeemable convertible preferred stock, net of issuance costs of $0

 

 

23

 

 

 

 

200

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Stock-based compensation expense

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

1,091

 

 

 

 

-

 

 

 

 

1,091

 

Exercise of stock options

 

 

-

 

 

 

 

-

 

 

 

38

 

 

 

 

-

 

 

 

 

43

 

 

 

 

-

 

 

 

 

43

 

Vesting of early exercised stock options

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

7

 

 

 

 

-

 

 

 

 

7

 

Donation of common stock and repurchase of unvested stock options

 

 

-

 

 

 

 

-

 

 

 

(188

)

 

 

 

-

 

 

 

 

(2

)

 

 

 

-

 

 

 

 

(2

)

Net loss

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

(4,908

)

 

 

 

(4,908

)

Balance at March 31, 2020

 

 

56,503

 

 

 $

 

138,191

 

 

 

24,496

 

 

 $

 

-

 

 

 $

 

18,517

 

 

 $

 

(85,165

)

 

 $

 

(66,648

)

Issuance of redeemable convertible preferred stock, net of issuance costs of $169

 

 

5,214

 

 

 

 

49,620

 

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

 

-

 

 

 

 

-

 

Stock-based compensation expense

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

9,395

 

 

 

 

-

 

 

 

 

9,395

 

Exercise of stock options

 

 

-

 

 

 

 

-

 

 

 

812

 

 

 

 

-

 

 

 

 

1,020

 

 

 

 

-

 

 

 

 

1,020

 

Vesting of early exercised stock options

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

5

 

 

 

 

-

 

 

 

 

5

 

Donation of common stock and repurchase of unvested stock options

 

 

-

 

 

 

 

-

 

 

 

(182

)

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Net loss

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

(11,715

)

 

 

 

(11,715

)

Balance at June 30, 2020

 

 

61,717

 

 

 $

 

187,811

 

 

 

25,126

 

 

 $

 

-

 

 

 $

 

28,937

 

 

 $

 

(96,880

)

 

 $

 

(67,943

)

Stock-based compensation expense

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

1,437

 

 

 

 

-

 

 

 

 

1,437

 

Exercise of stock options

 

 

-

 

 

 

 

-

 

 

 

532

 

 

 

 

-

 

 

 

 

310

 

 

 

 

-

 

 

 

 

310

 

Vesting of early exercised stock options

 

 

-

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

 

75

 

 

 

 

-

 

 

 

 

75

 

Net loss

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(2,574

)

 

 

 

(2,574

)

Balance at September 30, 2020

 

 

61,717

 

 

$

 

187,811

 

 

 

25,658

 

 

$

 

-

 

 

$

 

30,759

 

 

$

 

(99,454

)

 

$

 

(68,695

)

 

See accompanying notes to condensed consolidated financial statements.

 

8


 

AMPLITUDE, INC.

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)

(In thousands)

(unaudited)

 

 

 

Redeemable convertible
preferred stock

 

 

Class A and Class B common stock

 

 

 

Additional
paid-in

 

 

 

Accumulated

 

 

 

Total
stockholders’

 

 

 

Shares

 

 

 

Amount

 

 

Shares

 

 

 

Amount

 

 

 

capital

 

 

 

deficit

 

 

 

equity (deficit)

 

Balance at December 31, 2020

 

 

61,717

 

 

 $

 

187,811

 

 

 

27,924

 

 

 $

 

-

 

 

 $

 

37,704

 

 

 $

 

(104,824

)

 

 $

 

(67,120

)

Stock-based compensation expense

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

2,628

 

 

 

 

-

 

 

 

 

2,628

 

Exercise of stock options

 

 

-

 

 

 

 

-

 

 

 

1,226

 

 

 

 

-

 

 

 

 

1,488

 

 

 

 

-

 

 

 

 

1,488

 

Vesting of early exercised stock options

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

179

 

 

 

 

-

 

 

 

 

179

 

Net loss

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(6,439

)

 

 

 

(6,439

)

Balance at March 31, 2021

 

 

61,717

 

 

 $

 

187,811

 

 

 

29,150

 

 

 $

 

-

 

 

 $

 

41,999

 

 

 $

 

(111,263

)

 

 $

 

(69,264

)

Issuance of redeemable convertible preferred stock, net of issuance costs of $198

 

 

5,419

 

 

 

 

173,302

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

Stock-based compensation expense

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

3,085

 

 

 

 

-

 

 

 

 

3,085

 

Exercise of stock options

 

 

-

 

 

 

 

-

 

 

 

1,690

 

 

 

 

-

 

 

 

 

2,691

 

 

 

 

-

 

 

 

 

2,691

 

Vesting of early exercised stock options

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

480

 

 

 

 

-

 

 

 

 

480

 

Issuance of common stock in connection with an acquisition

 

 

-

 

 

 

 

-

 

 

 

1,070

 

 

 

 

-

 

 

 

 

7,402

 

 

 

 

-

 

 

 

 

7,402

 

Net loss

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

-

 

 

 

 

(10,083

)

 

 

 

(10,083

)

Balance at June 30, 2021

 

 

67,136

 

 

 $

 

361,113

 

 

 

31,910

 

 

 $

 

-

 

 

 $

 

55,657

 

 

 $

 

(121,346

)

 

 $

 

(65,689

)

Issuance of redeemable convertible preferred stock, net of issuance costs of $0

 

 

828

 

 

 

 

26,500

 

 

 

-

 

 

 

 

-